Physician profile
Fay Call
NPI 1629515556
$1,925.97
in general payments reported to CMS, 2019-2025
13 companies · $67.05 in 2025
The $67.05 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $46.78 · 2023: $75.57 · 2024: $1,604 · 2025: $67.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,201 · Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,200.97 |
| Food and Beverage | $545.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,301.24 | 2024 | |
| Amgen INC. | $124.99 | 2024 | Otezla |
| Astellas Pharma US INC | $116.32 | 2023-2025 | Veozah |
| Abbvie INC. | $98.81 | 2021-2023 | |
| Pfizer INC. | $56.36 | 2021-2024 | |
| Boston Scientific Corporation | $54.78 | 2024 | Solyx Sis System |
| Agile Therapeutics, INC. | $36.42 | 2021-2024 | Twirla |
| Celgene Corporation | $32.69 | 2024 | Zeposia |
| Mayne Pharma Commercial LLC | $29.07 | 2023 | |
| Hologic Sales and Service, LLC | $28.75 | 2021-2022 | |
| Shield Therapeutics INC | $19.36 | 2024 | |
| Therapeuticsmd, INC. | $14.74 | 2021 | |
| Exeltis, USA INC. | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fay Call listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.